These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 3068163

  • 1. Changes in serum and lipoprotein lipids, and apolipoprotein B and A-I, in patients with different types of primary hyperlipoproteinaemia treated with gemfibrozil.
    Sommariva D, Branchi A, Pini C, Scandiani L, Orlandi S, Fasoli A.
    Int J Clin Pharmacol Res; 1988; 8(5):383-92. PubMed ID: 3068163
    [Abstract] [Full Text] [Related]

  • 2. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.
    Lupien PJ, Brun D, Gagné C, Moorjani S, Bielman P, Julien P.
    Can J Cardiol; 1991; 7(1):27-33. PubMed ID: 2025787
    [Abstract] [Full Text] [Related]

  • 3. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA, Ylikahri R, Huttunen JK.
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [Abstract] [Full Text] [Related]

  • 4. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K, Sasaki J, Arakawa K.
    Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [Abstract] [Full Text] [Related]

  • 9. Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.
    Sirtori CR, Franceschini G, Gianfranceschi G, Sirtori M, Montanari G, Tremoli E, Maderna P, Colli S, Zoppi F.
    J Lab Clin Med; 1987 Sep; 110(3):279-86. PubMed ID: 3475394
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gemfibrozil in hyperlipidaemia: an open, single blind trial.
    Varthakavi PK, Turakhia DP, Sharma SS, Salgaonkar DS, Nihalani KD, Joshi VR.
    J Assoc Physicians India; 1990 Feb; 38(2):136-40. PubMed ID: 2380132
    [Abstract] [Full Text] [Related]

  • 13. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
    Hutt V, Klör HU, Wechsler JG, Ditschuneit H.
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Effect of bezafibrate on serum lipid, lipoprotein and apoprotein levels in patients with hyperlipoproteinemia type II and IV].
    Bednarska-Makaruk M, Kuźmińska A, Chotkowska E, Kurjata P, Polakowska M, Broda G, Rywik S.
    Pol Arch Med Wewn; 1992 Mar; 87(3):149-56. PubMed ID: 1523145
    [Abstract] [Full Text] [Related]

  • 18. [Multicenter study of the efficacy and tolerance of gemfibrozil and fenofibrate in the treatment of primary hyperlipoproteinemia].
    Manojlović D, Lepsanović L, Micić D, Sumarac M, Kendereski L, Popović V, Mićić J.
    Srp Arh Celok Lek; 1991 Mar; 119(1-2):22-5. PubMed ID: 1788614
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of ciprofibrate in primary type II and IV hyperlipidemia: the Italian multicenter study.
    Cattin L, Da Col PG, Feruglio FS, Finazzo L, Rimondi S, Descovich G, Manzato E, Zambon S, Crepaldi G, Siepi D.
    Clin Ther; 1990 Mar; 12(6):482-8. PubMed ID: 2289217
    [Abstract] [Full Text] [Related]

  • 20. [Beclobrate (Turec) in the treatment of primary hyperlipoproteinemia. II. Results of the treatment in relation to the type of hyperlipoproteinemia].
    Sznajd J, Idzior-Waluś B, Korzus G, Zabiński J, Hebda A, Markiewicz M.
    Przegl Lek; 1990 Mar; 47(10):711-4. PubMed ID: 2089450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.